VIA, Inc.Download PDFPatent Trials and Appeals BoardDec 24, 20202020002288 (P.T.A.B. Dec. 24, 2020) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 15/855,762 12/27/2017 John Charles Hepler 725.7070 9801 21707 7590 12/24/2020 ATIP Law 4790 Caughlin Parkway #701 RENO, NV 89519-0907 EXAMINER NELSON JR, MILTON ART UNIT PAPER NUMBER 3636 NOTIFICATION DATE DELIVERY MODE 12/24/2020 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): firm@AtipLaw.com pjpanzica@AtipLaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte JOHN CHARLES HEPLER Appeal 2020-002288 Application 15/855,762 Technology Center 3600 Before MURRIEL E. CRAWFORD, PHILIP J. HOFFMANN, and BRADLEY B. BAYAT, Administrative Patent Judges. HOFFMANN, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Pursuant to 35 U.S.C. § 134(a), Appellant1 appeals from the Examiner’s decision to reject claims 1–12. We have jurisdiction under 35 U.S.C. § 6(b). We REVERSE. 1 We use the term “Appellant” to refer to “applicant” as defined in 37 C.F.R. § 1.42. Appellant identifies the real party in interest as VIA, Inc. Appeal Br. 3. Appeal 2020-002288 Application 15/855,762 2 Appellant’s claims are directed to a chair. Independent claims 1 and 7 are the independent claims under appeal. Below, we reproduce independent claim 1 as illustrative of the appealed claims. 1. A chair comprising: (A) a frame; and (B) a support material that is supported by the frame and that provides a support for an occupant of the chair; wherein the support material comprises a mesh having a plurality of interwoven strands, wherein the plurality of interwoven strands comprise one or more interwoven strands that include a copper infusion. REJECTIONS AND PRIOR ART The Examiner rejects the claims as follows: I. Claims 1–3, 6–9, and 12 under 35 U.S.C. § 103 as unpatentable over Smith (US 2010/0181807 A1, published July 22, 2010) and Questel et al., (US 5,177,124, issued Jan. 5, 1993) (“Questel”); and II. Claims 4, 5, 10 and 11 under 35 U.S.C. § 103 as unpatentable over Smith, Questel, and Trinder, II et al., (US 2015/0320035 A1, published Nov. 12, 2015) (“Trinder”). OPINION Rejection I—Obviousness rejection of claims 1–3, 6–9, and 12 Independent claim 1 recites, in relevant part, “a support material that is supported by the frame and that provides a support for an occupant of the chair; wherein the support material comprises a mesh having a plurality of interwoven strands . . . [that] comprise[s] one or more interwoven strands that include a copper infusion.” Appeal Br., Claims App. Independent Appeal 2020-002288 Application 15/855,762 3 claim 7 includes a similar recitation. Id. The Examiner rejects the two independent claims based on similar reasoning. See Final Action 3–5. Specifically, the Examiner finds that Smith discloses a chair including “a support material (45),” but “with the exception of the one or more interwoven strands including a copper infusion.” Id. at 3. The Examiner finds that it is Questel that “teaches configuring a furniture article (see line 2 in column 9) as including a support material (plastic) that includes a copper infusion (see paragraph 3 in column 3).” Id. It appears that, at least initially, the Examiner determines that it would have been obvious to configure Smith’s “support material (i.e.[,] the interwoven strands and therefore one or more interwoven strands) as including a copper infusion” based on Questel’s disclosure of copper powder molded in plastic, because such a “modification enhances aesthetic appeal of the chair by providing an appearance that simulates a solid metal piece.”2 Id. Appellant argues that the Examiner’s rejection is in error because “[t]he Examiner has provided no explicit analysis nor provided a reasoned explanation as to how the person skilled in the art would perform the combination of Smith and Questel. Specifically, the Examiner has provided no explicit analysis as to how . . . [Smith’s] support material (i.e. interwoven strands) could be configured to include a copper infusion” as taught by Questel. Reply Br. 3. Based on our review of the record, we agree with Appellant. 2 Below, we also discuss the Examiner’s determination that it would have been obvious to replace Smith’s mesh material of interwoven strands with Questel’s material formed as a mesh material of interwoven strands. Appeal 2020-002288 Application 15/855,762 4 Appellant’s Specification describes that the mesh that is typically used in a mesh chair is replaced with a mesh including copper infused strands. The strands may be, for example, a polymer, nylon or similar type material to which a copper compound such as cuprous oxide, cuprous iodide etc. is added prior to the material being drawn into fibers or strands. Spec. ¶ 27 (cited at Appeal Br. 7). Smith discloses that [t]he seat 14 and the backrest 18 can each have a continuous sheet of flexible and elastic mesh (represented by 45 in FIG. 1a) held taut across and substantially covering the seat and backrest. The terms “mesh” and “sheet of mesh” are used interchangeably herein to refer to a mesh material that is a continuous sheet in that it essentially consistent in its composition of strands and intervening openings. Smith ¶ 64. Smith’s “continuous sheet of flexible and elastic mesh” can include a polypropelene [sic] mesh fabric or the like. The mesh can be a woven mesh or a knitted mesh. The mesh material can include 70% elastomer monofilament with a 55 durometer and 30% polyester yarn. The elastomeric monofilament can be a polyester co-polymer (such as Hytrel by Dupont). The interwoven monofilaments can also be bonded together to resist unraveling, for example by using a coextruded mono filament with an outer layer having a lower melting point that melts in an oven to bond to adjacent monofilaments. Id. Alternatively, Smith describes that the mesh could be “a plastic material that has a series or arrangement of openings across the sheet and that is continuous in that it is essentially consistent in its composition of structure and openings,” and “can be formed together, such as by injection molding.” Id. ¶ 65. Questel teaches a molding process, where metal particles are added to a resin/polyester plastic material, the metal particles “are permitted to settle” Appeal 2020-002288 Application 15/855,762 5 to the bottom of the mold, and non-metal floatable particles “will rise.” Questel col. 3, ll. 21–62. By adding both metal particles and floatable particles (such as hollow ceramic spheres), “[a]ny shrinkage in the object will be balanced on opposing surfaces of the object so it will not lose its desired shape due to uneven shrinkage of opposite faces which would occur if the object contained only the metal particles on one face of the object.” Id. at col. 3, ll. 44–47. The Examiner does not support adequately, such as by citing evidence or presenting a line of technical reasoning, that creating the claimed article is as simple as merely adding copper, as Questel discloses, to the material that forms Smith’s plastic mesh material. More specifically, it is not clear from the record that the proposed modification of adding copper to Smith’s plastic mesh material either would create a chair that would work (for example, a mesh material that would support the chair’s user), or would result in the expected aesthetic effect (i.e., that Smith’s chair would have “an appearance that simulates a solid metal piece” (Final Action 3)). In the Answer, the Examiner appears to change the basis of the rejection, from a determination that it would have been obvious to modify Smith’s plastic mesh material based on Questel, to a determination that it would have been obvious to replace Smith’s mesh material with a mesh material made from Questel’s material. See, e.g., Answer 7. However, the Examiner does not support adequately, such as with evidence or a line of technical reasoning, that “one of ordinary skill in the art could still produce strands for the same chair using a different plastic material taught by Questel (copper infused plastic).” Answer at 7. Again, for example, it is not clear from the record that Questel’s plastic material formed from resin, hollow Appeal 2020-002288 Application 15/855,762 6 ceramic spheres, and metal may be made into a mesh material capable of supporting the chair’s user. See, e.g., Reply Br. 4–5. The Examiner states that “Appellant provides no evidence that . . . [Questel’s] molding process is prohibitive to producing a strand that can be interwoven into a mesh.” Id. at 9. This is improper, however, because it is the Examiner who has the burden to support adequately that the proposed modification renders the claims obvious. See In re Warner, 379 F.2d 1011, 1016 (CCPA 1967) (“the precise language of 35 U.S.C. § 102 that ‘(a) person shall be entitled to a patent unless,’ concerning novelty and unobviousness, clearly places a burden of proof on the Patent Office which requires it to produce the factual basis for its rejection of an application under sections 102 and 103.”) Based on the foregoing, we do not sustain the Examiner’s obviousness rejection of independent claims 1 and 7. We also do not sustain the rejection of claims 2, 3, 6, 8, 9, and 12 that depend from, and the Examiner rejects with, the independent claims. Rejection II—Obviousness rejection of claims 4, 5, 10, and 11 Claims 4, 5, 10 and 11 depend from independent claims 1 and 7. The Examiner does not rely on Trinder to disclose anything that would remedy the above-discussed deficiency in the rejection of the independent claims. Consequently, we do not sustain the Examiner’s obviousness rejection of dependent claims 4, 5, 10, and 11. Appeal 2020-002288 Application 15/855,762 7 CONCLUSION We REVERSE the Examiner’s obviousness rejections of all of the claims. In summary: Claim(s) Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed 1–3, 6–9, 12 103 Smith, Questel 1–3, 6–9, 12 4, 5, 10, 11 103 Smith, Questel, Trinder 4, 5, 10, 11 Overall Outcome 1–12 REVERSED Copy with citationCopy as parenthetical citation